Panoscreen I, II, and III Reagent Red Blood Cell, 2-4% Suspension
Brand(s)
Last updated
Summary
Product
Panoscreen I, II, and III Reagent Red Blood Cell, 2-4% Suspension
Issue
Medical devices - Performance
What to do
Contact the manufacturer if you require additional information.
Audience
Healthcare
Affected products
| Affected products | Lot or serial number | Model or catalog number |
|---|---|---|
| Panoscreen I, II, and III Reagent Red Blood Cell, 2-4% Suspension | 17845 | 0002381 |
Issue
Some vials of Panoscreen, lot 17845, exhibit an unexpected dark color (hemolysis) and darkening of the red blood cells. It has been confirmed that there is fungal growth in the vials where the hemolysis and darkening of the red blood cells has been observed. This issue is random across kits within Panoscreen lot 17845 and is not present in all vials within the kit. Fungal contamination may lead to erroneous results.
Recall Start Date: June 6, 2024
Additional information
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Haematology
Companies
Immucor Inc.
3130 Gateway Drive, Norcross, Georgia, United States, 30071
Published by
Health Canada
Audience
Healthcare
Recall class
Type II
Identification number
RA-75776
Get notified
Receive notifications for new and updated recalls and alerts by category.